ZJYL Company Profile and Key Details

Jin Medical International Ltd. generated EPS of $0.01 over the past year. Five-year average earnings growth is -11.25%.

ZJYL has shown weak momentum, losing -46.6% over the past week and -59.9% over the past quarter, though year-to-date performance is down -40.0%. Short-term trend indicators are bullishly aligned (SMA20 5.67%, SMA50 -13.88%, SMA200 -66.72%). The stock’s 14-day RSI is 48.03 (neutral), while the ATR of 0.02 points to tighter daily ranges. The stock remains hovering near 52-week lows, trading -85.24% below its high and over 37.55% above its low. Average 10-day trading volume of 1.47 million shares is significantly above the 3-month average of 208.21 thousand, indicating heightened recent market interest.

Jin Medical International Ltd. has 156.55 million shares outstanding. The public float is 37.82 million shares, elevated short interest at 0.39% of float. This equals 191.34 thousand shares. The short ratio is 0.61 days. Institutional investors hold 0.48% of the float. Insiders own 86.95%.

Jin Medical International Ltd. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.84. This means the shares are trading below this model’s fair value.

Jin Medical International Ltd. (NASDAQ:ZJYL) closed at $2.15 USD, gaining $0.23 (11.98%) from the previous close of $1.92. The stock is currently mid-range between its 52-week high and low $1.53 and $17.18. With a market capitalization of about $16.83 million, Jin Medical International Ltd. is classified as a micro-cap and shows higher-than-market volatility (beta ~7.34). Key stats such as the average daily volume over the past year has been around 543.76 thousand shares, trading with heavier-than-usual volume. Headquartered in Changzhou, JS, Jin Medical International Ltd. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Erqi Wang, the company employs approximately 273 people and listed since March 28, 2023. Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement.

Our AI price prediction model suggests that Jin Medical International Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -9.77%, with price expected at $1.94 by August 21, 2026, within a range of $1.73 to $2.17 3-Month Outlook: Projected fall of -60.47%, reaching $0.85 by November 04, 2026, with a range of $0.44 to $1.30. 1-Year Outlook: Projected loss of -86.05%, with price at $0.30 by August 06, 2027, within a range of $0.00 to $0.00.

Jin Medical International Ltd. (NASDAQ:ZJYL) shares are down -40.0% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Jin Medical International Ltd. trading at a premium to the broader market with a P/E of 15.12. Our AI forecast model points to short-term weakness (-9.77% over two weeks), a medium-term fall (-60.47% over three months), and a longer-term loss (-86.05% over one year), with expected trading ranges indicating moderate volatility.

Jin Medical International Ltd. trades at a P/E ratio of 15.12, slightly below the S&P 500 average, with a price-to-sales ratio of 0.88 and a price-to-book ratio of 0.57 suggesting the stock is closer to book value. The P/FCF stands at -2.49, also below market averages.